Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ALUMIS INC | 4,619,803 | 4,528,408 | -91,395 | 45,089 | 99,761 | 35.56% | +54,672 |
| ALX ONCOLOGY HLDGS INC | 9,699,925 | 12,884,638 | +3,184,713 | 10,961 | 25,834 | 9.21% | +14,873 |
| LYELL IMMUNOPHARMA INC | 0 | 337,697 | +337,697 | 0 | 6,774 | 2.41% | +6,774 |
| PHARVARIS N V COM | 4,639,304 | 4,639,304 | 0 | 128,741 | 131,060 | 46.71% | +2,320 |
| ARTIVA BIOTHERAPEUTICS INC | 648,507 | 531,337 | -117,170 | 2,782 | 3,422 | 1.22% | +640 |
| HARMONY BIOSCIENCES HLDGS IN(HRMY) | 489,194 | 489,194 | 0 | 18,306 | 13,702 | 4.88% | -4,603 |
| LYELL IMMUNOPHARMA INC | 337,697 | 0 | -337,697 | 10,394 | 0 | — | -10,394 |